
CAS: 1473404-51-1
Ordinare per
5 prodotti.
(E)-4-((3-Chlorophenyl)Diazenyl)-5-Hydroxy-3-(4-Nitrophenyl)-1H-Pyrazole-1-Carbothioamide
CAS:(E)-4-((3-Chlorophenyl)Diazenyl)-5-Hydroxy-3-(4-Nitrophenyl)-1H-Pyrazole-1-CarbothioamidePurezza:97%Peso molecolare:402.81g/molHck-IN-1
CAS:Hck-IN-1 selectively inhibits Nef:Hck, IC50: 2.8 μM; >20 μM for Hck alone. Potent HIV-1 Nef antagonist, IC50: 100-300 nM for HIV-1 replication.Formula:C16H11ClN6O3SPurezza:99.07%Colore e forma:SolidPeso molecolare:402.81Ref: TM-T11538
1mg97,00€5mg216,00€10mg344,00€25mg567,00€50mg825,00€100mg1.121,00€200mg1.510,00€1mL*10mM (DMSO)240,00€(E)-4-((3-Chlorophenyl)diazenyl)-5-hydroxy-3-(4-nitrophenyl)-1H-pyrazole-1-carbothioamide
CAS:Formula:C16H11ClN6O3SPurezza:97%Peso molecolare:402.8149HCK-IN-1
CAS:HCK-IN-1 is a peptide that was originally isolated from the venom of the black mamba and has been shown to activate potassium ion channels. HCK-IN-1 is an inhibitor of voltage activated sodium and calcium channels, which are important in cardiac excitation. It also has been shown to have anti-inflammatory effects by inhibiting the production of cytokines such as IL-6, TNF-α, and IL-8. HCK-IN-1 has potential applications in cell biology research as it is a high purity, potent activator of potassium ion channels. The peptide can also be used to inhibit voltage activated sodium and calcium channels in cardiac cells.Formula:C16H11ClN6O3SPurezza:Min. 95%Peso molecolare:402.8 g/mol